跳轉至內容
Merck
全部照片(1)

重要文件

235989

Sigma-Aldrich

Brij® L4聚氧乙烯月桂醚

average Mn ~362

同義詞:

四聚乙二醇单月桂醚, 聚氧乙烯 (4) 月桂醚

登入查看組織和合約定價


About This Item

線性公式:
(C20H42O5)n
CAS號碼:
MDL號碼:
分類程式碼代碼:
12161900
PubChem物質ID:
NACRES:
NA.21

描述

non-ionic

品質等級

分子量

average Mn ~362

折射率

n20/D 1.451 (lit.)

密度

0.95 g/mL at 25 °C (lit.)

HLB

9

SMILES 字串

CCCCCCCCCCCCOCCOCCOCCOCCO

InChI

1S/C20H42O5/c1-2-3-4-5-6-7-8-9-10-11-13-22-15-17-24-19-20-25-18-16-23-14-12-21/h21H,2-20H2,1H3

InChI 密鑰

WPMWEFXCIYCJSA-UHFFFAOYSA-N

尋找類似的產品? 前往 產品比較指南

一般說明

Brij® L4 是一种非离子表面活性剂。它含有一个连接氧乙烯基头基的烷基(C12)尾。

應用

Brij® L4 已被用于:
  • 作为表面活性剂采用微乳液技术合成氧化铜(I)(Cu2O) 球形纳米颗粒
  • 作为非离子表面活性剂用于制备反胶束以合成Pt3Co 合金纳米颗粒
  • 作为表面活性剂用于改善疏水材料界面偶联的效率并生成水凝胶

生化/生理作用

Brij® L4 具有两亲性。Brij L4 含有疏水和亲水区域,可以形成胶束并使疏水药物分散进入胶束核中。这相应地改善了药物的溶解性。Brij L4也对乳腺癌耐药蛋白(BCRP)介导的药物外排有强烈的抑制作用。与其它常用表面活性剂相比,它对Taq吸附的抑制作用更强。Brij L4 有助于在标准Taq浓度下进行皮升反应体积的液滴聚合酶链式反应(PCR)。

法律資訊

Brij is a registered trademark of Croda International PLC

象形圖

Exclamation markEnvironment

訊號詞

Warning

危險分類

Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Irrit. 2 - Skin Irrit. 2

儲存類別代碼

10 - Combustible liquids

水污染物質分類(WGK)

WGK 2

閃點(°F)

Not applicable

閃點(°C)

Not applicable

個人防護裝備

dust mask type N95 (US), Eyeshields, Gloves


從最近期的版本中選擇一個:

分析證明 (COA)

Lot/Batch Number

未看到正確版本?

如果您需要一個特定的版本,您可以透過批號來尋找特定憑證。

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Copper (i) oxide nanoparticle-mediated C-C couplings for synthesis of polyphenylenediethynylenes: Evidence for a homogeneous catalytic pathway
Pary FF, et al.
Catalysis Science & Technology, 11(7), 2414-2421 (2021)
Synthesis of Pt3Co alloy nanocatalyst via reverse micelle for oxygen reduction reaction in PEMFCs
Liu Z, et al.
Topics in Catalysis, 49(3), 241-250 (2008)
Paul Le Floch et al.
ACS applied materials & interfaces, 9(30), 25542-25552 (2017-07-12)
The emergence of stretchable electronics and its potential integration with textiles have highlighted a challenge: Textiles are wearable and washable, but electronic devices are not. Many stretchable conductors have been developed to enable wearable active textiles, but little has been
Otte Brosjö et al.
Acta orthopaedica, 84(5), 502-505 (2013-11-01)
Recent data suggest that percutaneous sclerotherapy is a safe alternative to surgery for treatment of aneurysmal bone cysts (ABCs). We present our experience of this method. We retrospectively analyzed data from 38 consecutive patients treated with repeated injections of polidocanol.
Darío Morais et al.
Rhinology, 50(1), 80-86 (2012-04-04)
Hereditary Haemorrhagic Telangiectasia or Rendu-Osler-Weber syndrome is a rare autosomal dominant vascular disease characterized by mucocutaneous and gastrointestinal telangiectases and localized arteriovenous malformations in lung, brain and liver. Epistaxis, due to rupture of telangiectases of the nasal mucosa, is the

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務